These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 507608)

  • 1. [Various therapeutic effects of piracetam (1st part)].
    Houillon P; Kitenge A; Jouannigot R; Lullien L; Cadic F
    Ann Med Psychol (Paris); 1979 Sep; 137(6-7):605-10. PubMed ID: 507608
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effects of Nootropyl].
    Houillon P; Kitenge A; Jouannigot R; Lullien L
    Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of metabolically active preparations to study mild forms of mental deficiency].
    Ermolina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):439-43. PubMed ID: 7395427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective action of metabolic drug therapy in mentally retarded children].
    Avrutskaia IG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):436-9. PubMed ID: 7395426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of UCB (piracetam) 6215 in infantile (and adult) neuropsychiatry].
    Lafon R; Pouget R; Chiariny JF; Bertier JF; Darius J
    Ann Med Psychol (Paris); 1972; 2(3):425-31. PubMed ID: 4648231
    [No Abstract]   [Full Text] [Related]  

  • 9. [The efficacy of Piracetam on the mental functional capacity of chronic alcoholics (author's transl)].
    Binder S; Doddabela P
    Med Klin; 1976 Apr; 71(17):711-6. PubMed ID: 775275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nootropic agents on serum biochemical indices in intellectually deficient children].
    Turova NF; Ermolina LA; Baryshnikov VA; Kopaladze RA; Aziavchik AV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1558-63. PubMed ID: 6686404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of piracetam on the aggregation of platelets (author's transl)].
    Vömel T; Platt D; Summa JD
    Aktuelle Gerontol; 1982 Jan; 12(1):12-4. PubMed ID: 6121499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the effects of piracetam and aminalone in experimental neuroses in the dog].
    Mekhedova AIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(5):964-6. PubMed ID: 6685954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of Alzheimer's disease. Problems of the criteria of clinical trials of nootropic drugs].
    Hirai S
    Nihon Rinsho; 1988 Jul; 46(7):1592-9. PubMed ID: 3221466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piracetam in the treatment of language disorders in children].
    Trevisio A; Rigardetto R
    Minerva Pediatr; 1977 May; 29(19):1267-72. PubMed ID: 882070
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlations between biological and clinical indices in children with intellectual deficiencies].
    Ermolina LA; Baryshnikov VA; Gorbachevskaia NL; Turova NF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):59-62. PubMed ID: 7080778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium].
    Ulbricht B
    Med Welt; 1976 Oct; 27(40):1912-5. PubMed ID: 790079
    [No Abstract]   [Full Text] [Related]  

  • 19. Piracetam in chronic brain failure.
    Lloyd-Evans S; Brocklehurst JC; Palmer MK
    Curr Med Res Opin; 1979; 6(5):351-7. PubMed ID: 540525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of piracetam in models of experimental inflammation.
    Nikolova M; Petrova L; Dushkova R
    Int J Tissue React; 1984; 6(1):17-21. PubMed ID: 6715116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.